164 related articles for article (PubMed ID: 38201211)
21. Identifying novel ovarian tumor biomarkers through mining of the transcriptome of circulating immune cells: A proof-of-concept study.
Uppal S; Medlin E; Felder M; Kapur A; Sterner RC; Vazquez J; Lindner PN; Stanic AK; Barroilhet L; Gonzalez-Bosquet J; Patankar MS
Am J Reprod Immunol; 2021 Oct; 86(4):e13469. PubMed ID: 34022086
[TBL] [Abstract][Full Text] [Related]
22. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
Guo Z; Wang H; Meng F; Li J; Zhang S
J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
[TBL] [Abstract][Full Text] [Related]
23. Confocal backscattering-based detection of leukemic cells in flowing blood samples.
Greiner C; Hunter M; Rius F; Huang P; Georgakoudi I
Cytometry A; 2011 Oct; 79(10):874-83. PubMed ID: 21638765
[TBL] [Abstract][Full Text] [Related]
24. Immune Monitoring of Cancer Patients by Multi-color Flow Cytometry.
Neo SY; O'Reilly A; Pico de Coaña Y
Methods Mol Biol; 2019; 1913():49-65. PubMed ID: 30666598
[TBL] [Abstract][Full Text] [Related]
25. Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer.
Matsuzaki J; Lele S; Odunsi K; Tsuji T
Oncoimmunology; 2022; 11(1):2020983. PubMed ID: 35003898
[TBL] [Abstract][Full Text] [Related]
26. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
27. The expression of Tim-3 in peripheral blood of ovarian cancer.
Wu J; Liu C; Qian S; Hou H
DNA Cell Biol; 2013 Nov; 32(11):648-53. PubMed ID: 24007284
[TBL] [Abstract][Full Text] [Related]
28. Clinical applications of monitoring immune status with 90 immune cell subsets in human whole blood by 10-color flow cytometry.
Wang W; Li H; Zhang L; Jiang W; Shen L; Fan G
Int J Lab Hematol; 2021 Oct; 43(5):1132-1144. PubMed ID: 33870648
[TBL] [Abstract][Full Text] [Related]
29. Organ-on-a-chip models for development of cancer immunotherapies.
Chernyavska M; Masoudnia M; Valerius T; Verdurmen WPR
Cancer Immunol Immunother; 2023 Dec; 72(12):3971-3983. PubMed ID: 37923890
[TBL] [Abstract][Full Text] [Related]
30. Inertial microfluidics for sheath-less high-throughput flow cytometry.
Bhagat AA; Kuntaegowdanahalli SS; Kaval N; Seliskar CJ; Papautsky I
Biomed Microdevices; 2010 Apr; 12(2):187-95. PubMed ID: 19946752
[TBL] [Abstract][Full Text] [Related]
31. A portable battery powered microfluidic impedance cytometer with smartphone readout: towards personal health monitoring.
Talukder N; Furniturewalla A; Le T; Chan M; Hirday S; Cao X; Xie P; Lin Z; Gholizadeh A; Orbine S; Javanmard M
Biomed Microdevices; 2017 Jun; 19(2):36. PubMed ID: 28432532
[TBL] [Abstract][Full Text] [Related]
32. CXCR6 by increasing retention of memory CD8
Muthuswamy R; McGray AR; Battaglia S; He W; Miliotto A; Eppolito C; Matsuzaki J; Takemasa T; Koya R; Chodon T; Lichty BD; Shrikant P; Odunsi K
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34607898
[TBL] [Abstract][Full Text] [Related]
33. Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy.
Zaborowski MP; Stefens-Stawna P; Osztynowicz K; Piorunek T; Batura-Gabryel H; Dyzmann-Sroka A; Kozubski W; Nowak-Markwitz E; Michalak S
Cancer Immunol Immunother; 2021 May; 70(5):1277-1289. PubMed ID: 33136178
[TBL] [Abstract][Full Text] [Related]
34. Ultraportable Flow Cytometer Based on an All-Glass Microfluidic Chip.
Li J; Cui Y; Xie Q; Jiang T; Xin S; Liu P; Zhou T; Li Q
Anal Chem; 2023 Jan; 95(4):2294-2302. PubMed ID: 36654498
[TBL] [Abstract][Full Text] [Related]
35. The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool For Ovarian Cancer Immunotherapy Research.
Rodriguez GM; Galpin KJC; Cook DP; Yakubovich E; Maranda V; Macdonald EA; Wilson-Sanchez J; Thomas AL; Burdette JE; Vanderhyden BC
Cancer Res Commun; 2022 Jun; 2(6):417-433. PubMed ID: 36311166
[TBL] [Abstract][Full Text] [Related]
36. Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients.
Zou Z; Lin Z; Wu C; Tan J; Zhang J; Peng Y; Zhang K; Li J; Wu M; Zhang Y
Adv Sci (Weinh); 2023 Sep; 10(27):e2302640. PubMed ID: 37485650
[TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of regulatory T cells monitoring in the peripheral blood of ovarian cancer patients.
Brtnický T; Fialová A; Laštovička J; Rob L; Špíšek R
Hum Immunol; 2015 Mar; 76(2-3):187-91. PubMed ID: 25514665
[TBL] [Abstract][Full Text] [Related]
38. Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution.
Kumar A; Parihar A; Panda U; Parihar DS
ACS Appl Bio Mater; 2022 May; 5(5):2046-2068. PubMed ID: 35473316
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cancer immunotherapy using mini-tumor chips.
Ao Z; Cai H; Wu Z; Hu L; Li X; Kaurich C; Gu M; Cheng L; Lu X; Guo F
Theranostics; 2022; 12(8):3628-3636. PubMed ID: 35664082
[No Abstract] [Full Text] [Related]
40. Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry.
Ma W; Wei S; Long S; Tian EC; McLaughlin B; Jaimes M; Montoya DJ; Viswanath VR; Chien J; Zhang Q; Van Dyke JE; Chen S; Li T
Front Immunol; 2023; 14():1206631. PubMed ID: 37638022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
